DeepX Health selected to present at Nordic Life Science Days

DeepX Health has been selected to present at NLS Days 2021, the largest Nordic partnering conference dedicated to the life science industry. Having been selected from hundreds of high-quality applicants, DeepX Health will be given the opportunity to pitch the company for a record-high 95+ global investors as one of 80 Rising Stars - companies that represent the best investment opportunity.

 

A fully virtual event due to the ongoing pandemic, DeepX Health will present in a video format. We look forward to share more about ourselves and our vision for the future at the conference!

April 2, 2024

Telehealth Pioneer Paul Johnson Joins DeepX Health Advisory Board

Read more

March 13, 2024

DeepX Health Welcomes Renowned Researcher and Entrepreneur Andre Esteva to Advisory Board

Read more

July 11, 2023

DeepX Health’s DermoSight featured on BBC

Read more

July 10, 2023

DeepX Health’s DermoSight at NHS event on 12 July

Read more

June 6, 2023

DeepX Diagnostics Inc.'s DermoSight Receives FDA Clearance for Teledermatology Screening of Suspect Skin Cancer Lesions

Read more

June 2, 2023

DeepX Health’s Skin Cancer Teledermoscopy Services Now in Jersey

Read more

November 29, 2021

New Board Advisor to DeepX Health

Read more

March 30, 2021

New Head of Product at DeepX Health

Read more

December 15, 2020

Pharmacy Screening Demonstrates Great Efficiency and Potential for Cost Reductions

Read more

October 23, 2020

Primary Care Setting Pilot Launched with NHS

Read more

October 14, 2020

DeepX Health to Present at the 8th World Congress of Teledermatology, Imaging and Artificial Intelligence for Skin Diseases

Read more

September 30, 2020

ScreenCancer Awarded Support for Diagnostic Triage Algorithm-Project

Read more

January 8, 2020

DeepX Health to participate at the 7th Annual Dermatology Summit in San Francisco

Read more

December 13, 2019

DeepX Health to present at Digital Health World Congress in London

Read more

December 3, 2019

DeepX Health participate in the DxPx Conference

Read more

December 1, 2019

ScreenCancer approved for first round of Horizon 2020 programme

Read more